Bogle Investment Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-26,647
Closed -$2.98M 215
2020
Q3
$2.98M Sell
26,647
-8,384
-24% -$969K 0.87% 49
2020
Q2
$3.26M Sell
35,031
-43,388
-55% -$3.69M 0.54% 84
2020
Q1
$5.75M Sell
78,419
-27,444
-26% -$2.38M 0.6% 71
2019
Q4
$8.9M Buy
105,863
+9,304
+10% +$720K 0.83% 46
2019
Q3
$8.12M Buy
+96,559
New +$7.3M 0.7% 66
2019
Q1
Sell
-133,723
Closed -$7.08M 347
2018
Q4
$7.08M Sell
133,723
-117,996
-47% -$6.48M 0.55% 76
2018
Q3
$15.1M Buy
+251,719
New +$13.8M 1.08% 20
2018
Q1
Sell
-9,736
Closed -$353K 348
2017
Q4
$353K Buy
+9,736
New +$341K 0.03% 254
2017
Q1
Sell
-11,772
Closed -$424K 350
2016
Q4
$424K Buy
+11,772
New +$392K 0.03% 299

Other funds holding MEDP

Bogle Investment Management's MEDP Position: Q4 2020 in Review

Bogle Investment Management sold out of Medpace (MEDP) in Q4 2020, closing a stake of 26,647 shares — an estimated $2.98M sold.

Bogle Investment Management first reported a position in MEDP in Q4 2016 and held it in 9 quarters. The position peaked at $15.1M in Q3 2018. 316 funds tracked by Wall St. Rank hold MEDP as of Q4 2020.

  • Bogle Investment Management reported no remaining Medpace position as of Q4 2020 after selling out during the quarter.
  • Bogle Investment Management sold 26,647 Medpace shares in Q4 2020, an estimated $2.98M.
  • Bogle Investment Management first reported a position in Medpace in Q4 2016 and held it in 9 quarters.
  • Bogle Investment Management's Medpace position peaked at $15.1M in Q3 2018.
  • 316 funds tracked by Wall St. Rank held Medpace as of Q4 2020.

Based on Bogle Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.